PVS ratio comparisons across different variables using box plots with statistical comparison annotations for TP(a), DOSE(b), Shunt(c), Anesthesia(d), and Sex(e). by Ruitian Song (11045127)

Subjects:

PVS_volume changes, ΔPVS_volumes, for various radiation doses within each treatment period: 0M–3M(a), 3M–12M(b), and 12M–FollowUp(c). by Ruitian Song (11045127)

Subjects:

The dataset for the paired model. by Ruitian Song (11045127)

Subjects:

Patient enrollment and inclusion information. by Ruitian Song (11045127)

Subjects:

Changes of PVS ratios and volumes for different treatment periods and different dose levels (HD: high dose, SD: standard dose, and RD: reduced dose). by Ruitian Song (11045127)

Subjects:

The dataset for the full model analysis. by Ruitian Song (11045127)

Subjects:

Effect of Rut on neuronal injury caused by OGD. by Zhixuan Huang (6750410)

Subjects:

Effects of LTS on G_s. by Lifeng Guo (17320116)

Effects of LTS on T_r. by Lifeng Guo (17320116)

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P_i-induced VSMCs. …”

RcbA and RcbB co-operatively decrease motility independent of CaCl₂ concentration. by Shobnom Mustaree (21728815)

<i>Porphyromonas gingivalis</i> LPS pretreated by ozone ultrafine bubble water induces decreased TLR2 activation. by Mana Endo (22430706)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Picosecond Lifetimes of Hydrogen Bonds in the Halide Perovskite CH₃NH₃PbBr₃ by Alejandro Garrote-Márquez (16796896)

Subjects:

Picosecond Lifetimes of Hydrogen Bonds in the Halide Perovskite CH₃NH₃PbBr₃ by Alejandro Garrote-Márquez (16796896)

Subjects:

Picosecond Lifetimes of Hydrogen Bonds in the Halide Perovskite CH₃NH₃PbBr₃ by Alejandro Garrote-Márquez (16796896)

Subjects:

Picosecond Lifetimes of Hydrogen Bonds in the Halide Perovskite CH₃NH₃PbBr₃ by Alejandro Garrote-Márquez (16796896)

Subjects:

Quantile regression results of male triathletes. by Junhui Zhao (626062)

Subjects:

Picosecond Lifetimes of Hydrogen Bonds in the Halide Perovskite CH₃NH₃PbBr₃ by Alejandro Garrote-Márquez (16796896)

Subjects: